LBO of a $30+ million drug packaging and labeling business

HPIS built a detailed model with plant & personnel expansion scenarios; the model included an item-by-item income statement forecast and consolidation of 2 corporate entities through merger following acquisition. We also conducted an in-depth study of the pharmaceuticals supply chain including drug manufacturing, distribution, packaging, payment sources, and retail pharmacies and identified avenues for growth post-acquisition. Our materials were used to raise senior debt, mezzanine, and equity capital for the transaction.